Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.
作者信息
Ungar Benjamin, Pavel Ana B, Li Randall, Kimmel Grace, Nia John, Hashim Peter, Kim Hee Jin, Chima Margot, Vekaria Anjali S, Estrada Yeriel, Xu Hui, Peng Xiangyu, Singer Giselle K, Baum Danielle, Mansouri Yasaman, Taliercio Mark, Guttman-Yassky Emma
机构信息
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY.
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY; Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY; Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY.
出版信息
J Allergy Clin Immunol. 2021 Jan;147(1):394-397. doi: 10.1016/j.jaci.2020.04.055. Epub 2020 May 16.
PMID:32428528
Abstract
摘要
Zotero 插件